Key result
Breast cancer treatments are associated with varying rates of venous thromboembolism depending on the specific time windows before, during, and following therapy.
Answers are grounded in this paper and cite their sources.
Highlights the importance of timing when assessing venous thromboembolism risk associated with breast cancer treatments.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Paulus et al. (2016) studied this question. Breast cancer treatments are associated with varying rates of venous thromboembolism depending on the specific time windows before, during, and following therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: